KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Other: 2020-2025

Historic Receivables - Other for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Sep 2025 value amounting to $11.2 million.

  • Ginkgo Bioworks Holdings' Receivables - Other rose 38.27% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 38.27%. This contributed to the annual value of $11.3 million for FY2024, which is 11.88% up from last year.
  • Ginkgo Bioworks Holdings' Receivables - Other amounted to $11.2 million in Q3 2025, which was up 2.75% from $10.9 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Receivables - Other peaked at $11.3 million during Q4 2024, and registered a low of $300,000 during Q2 2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Receivables - Other value was $10.8 million (recorded in 2024), while the average stood at $9.1 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 2,066.67% in 2022, then tumbled by 58.47% in 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Receivables - Other (Quarterly) stood at $4.6 million in 2021, then rose by 2.10% to $6.2 million in 2022, then plummeted by 58.47% to $10.1 million in 2023, then grew by 11.88% to $11.3 million in 2024, then spiked by 38.27% to $11.2 million in 2025.
  • Its Receivables - Other stands at $11.2 million for Q3 2025, versus $10.9 million for Q2 2025 and $11.3 million for Q4 2024.